Natural Flavonoids in the Prevention and Treatment of Lung Cancer: A Pharmacological Aspect

被引:9
作者
Nath, Rajat [1 ]
Das, Chandrima [1 ]
Kityania, Sibashish [1 ]
Nath, Deepa [2 ]
Das, Subrata [1 ]
Choudhury, Manabendra Dutta [1 ]
Patra, Jayanta Kumar [3 ]
Das Talukdar, Anupam [1 ]
机构
[1] Assam Univ, Dept Life Sci & Bioinformat, Silchar, Assam, India
[2] Guru Charan Coll, Dept Bot, Silchar, Assam, India
[3] Dongguk Univ, Res Inst Biotechnol & Med Converged Sci, Seoul, South Korea
关键词
Cancer; lung cancer; natural products; flavonoids; pharmacology; phytochemicals; CELL-CYCLE ARREST; NF-KAPPA-B; STEM-LIKE CELLS; INDUCED APOPTOSIS; DOWN-REGULATION; UP-REGULATION; EPIGALLOCATECHIN GALLATE; CASTICIN SUPPRESSES; SELF-RENEWAL; A549; CELLS;
D O I
10.2174/1386207325666220701121537
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Deadly disease cancer has many types; among them, lung cancer is responsible for the highest number of cancer mortality. Existing therapies as well as drugs for treating lung cancer are not effective and are often associated with innumerable side effects and toxicities. For these reasons, researchers have been working on developing novel anti-cancer medicines from plants and other natural sources that have a high safety profile. Natural flavonoids are a polyphenolic group of phytochemicals extracted from plants and other plant-derived compounds. Natural flavonoids are gaining popularity due to their unique and priceless medicinal properties, including anticancer properties. Several researchers have already declared that flavonoids possess the ability to treat different cancers, particularly lung cancer. The bioactivity of natural flavonoids is mainly due to their structural diversity. Natural flavonoids fight against lung cancer by regulating redox homeostasis, upregulating apoptosis, pro-apoptotic factors, and survival genes, arresting cell cycle progression, autophagy, reducing cell proliferation and invasiveness, maintaining inflammation response, downregulating anti-apoptotic factors, and targeting lung cancer signaling pathways. Flavonoids can act alone or synergistically with other agents to treat lung cancer. Due to these reasons, it is possible to use natural flavonoids as pharmaceutical leads to prevent and treat lung cancer.
引用
收藏
页码:863 / 879
页数:17
相关论文
共 131 条
[1]   Flavonoids in Cancer and Apoptosis [J].
Abotaleb, Mariam ;
Samuel, Samson Mathews ;
Varghese, Elizabeth ;
Varghese, Sharon ;
Kubatka, Peter ;
Liskova, Alena ;
Buesselberg, Dietrich .
CANCERS, 2019, 11 (01)
[2]  
Baruah T.J., 2019, NEHU, VXVII, P22
[3]   Anti-cancer potential of flavonoids: recent trends and future perspectives [J].
Batra, Priya ;
Sharma, Anil K. .
3 BIOTECH, 2013, 3 (06) :439-459
[4]   A comprehensive and current review on the role of flavonoids in lung cancer-Experimental and theoretical approaches [J].
Berk, Seyda ;
Kaya, Savas ;
Akkol, Esra Kupeli ;
Bardakci, Hilal .
PHYTOMEDICINE, 2022, 98
[6]   Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma [J].
Bie, Beibei ;
Sun, Jin ;
Guo, Ying ;
Li, Jun ;
Jiang, Wei ;
Yang, Jun ;
Huang, Chen ;
Li, Zongfang .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 93 :1285-1291
[7]  
Brodowska KM., 2017, EUROPEAN J BIOL RES, DOI [10.5281/zenodo.545778, DOI 10.5281/ZENODO.545778]
[8]   Scutellarin suppresses proliferation and promotes apoptosis in A549 lung adenocarcinoma cells via AKT/mTOR/4EBP1 and STAT3 pathways [J].
Cao, Pikun ;
Liu, Bin ;
Du, Feng ;
Li, Dong ;
Wang, Yongzheng ;
Yan, Xiaoyan ;
Li, Xiao ;
Li, Yuliang .
THORACIC CANCER, 2019, 10 (03) :492-500
[9]   Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo [J].
Cathcart, Mary-Clare ;
Useckaite, Zivile ;
Drakeford, Clive ;
Semik, Vikki ;
Lysaght, Joanne ;
Gately, Kathy ;
O'Byrne, Kenneth J. ;
Pidgeon, Graham P. .
BMC CANCER, 2016, 16
[10]   Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and-9 [J].
Chang, Huai-Lu ;
Chang, Yuh-Ming ;
Lai, Shih-Chan ;
Chen, Ke-Min ;
Wang, Kuan-Chu ;
Chiu, Tsu-Ting ;
Chang, Fu-Hsin ;
Hsu, Li-Sung .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (02) :739-744